EMA CHMP Chair Re-elected
Tomas Salmonson is re-elected as Chair of the Committee for Medicinal Products for Human Use.
The European Medicines Agency (EMA) announced on Sept. 21, 2015 that Dr. Tomas Salmonson has been re-elected as Chair of the Committee for Medicinal Products for Human Use (CHMP). Salmonson is senior scientific advisor at the Swedish Medical Products Agency, has been a member of CHMP for more than 15 years, and has served as CHMP chair for the past three years.
According to an EMA press release, in his second term, Salmonson plans on deepening stakeholder collaboration, facilitating the development of and access to innovative medicines, and improving benefit-risk methodologies.
In response to his re-election, Salmonson stated, “It is a great honor for me to receive the backing of my peers for another term. I have a deep respect and appreciation for the work of the dedicated and professional members of the Committee. CHMP is a forum for open discussion. Debate between members with different backgrounds and views is an essential element in delivering robust scientific opinions. I look forward to working even harder to maintain and strengthen this fruitful working environment in order to fulfill our public health mandate.”
Source: European Medicines Agency
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
